文献速递骨软组织肉瘤与黑色素瘤

单纯手术治疗足以治疗低危滑膜肉瘤儿童和青少年:欧洲儿童软组织肉瘤研究组与儿童肿瘤学组的联合分析

Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group.
PubMed 文献 · Eur J Cancer · 2017-04-07

该联合分析汇总EpSSG NRSTS2005和COG ARST0332两项前瞻性临床试验中仅接受手术治疗的低危局限期滑膜肉瘤患者数据,共纳入60例年龄<21岁、完整切除且切缘阴性、2级任何大小或3级≤5 cm的患者。3年无事件生存率为90%,8例事件均为局部复发,无转移复发,所有复发患者均获有效挽救,总生存率100%。

要点

  • 低危滑膜肉瘤患者(完整切除、切缘阴性、2级任何大小或3级≤5 cm)仅手术治疗的3年无事件生存率为90%。
  • 所有8例事件均为局部肿瘤复发,未见转移复发,复发患者均获有效挽救,总生存率100%。
  • 避免辅助化疗和放疗可能降低该低危人群的短期和长期发病率与死亡率。

核心结论

  • 这项联合前瞻性分析显示,完整切除的≤5 cm滑膜肉瘤患者无论分级如何,仅手术治疗是安全的。
  • 避免在该低危人群中使用辅助化疗和放疗可能降低短期和长期发病率与死亡率。

研究设计与样本

  • 汇总欧洲儿童软组织肉瘤研究组(EpSSG)NRSTS2005和儿童肿瘤学组(COG)ARST0332两项前瞻性临床试验中仅接受手术治疗的患者数据。
  • 纳入标准为局限期滑膜肉瘤、初始完整切除且组织学切缘阴性、2级肿瘤任何大小或3级肿瘤≤5 cm。
  • 共60例年龄<21岁患者符合条件,其中36例入组COG(2007年至2012年),24例入组EpSSG研究(2005年至2012年)。

主要发现

  • 3年无事件生存率为90%,中位随访5.2年(范围1.9-9.1年)。
  • 全部8例事件均为局部肿瘤复发,未见转移复发。
  • 所有复发患者均获有效挽救,总生存率为100%。

关键数值与推荐

  • 低危滑膜肉瘤仅手术治疗的纳入标准:初始完整切除且组织学切缘阴性,2级肿瘤任何大小或3级肿瘤≤5 cm。
  • 3年无事件生存率为90%,中位随访5.2年(范围1.9-9.1年),总生存率100%。

临床怎么用

  • 对于完整切除的≤5 cm滑膜肉瘤患者,无论分级如何,可安全地仅采用手术治疗。
  • 在该低危人群中避免辅助化疗和放疗可能降低短期和长期发病率与死亡率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multimodal risk-adapted treatment is used in paediatric protocols for synovial sarcoma (SS). Retrospective analyses suggest that low-risk SS patients can be safely treated with surgery alone, but no prospective studies have confirmed the safety of this approach. This analysis pooled data from the two prospective clinical trials to assess outcomes in SS patients treated with a surgery-only approach and to identify predictors of treatment failure. METHODS: Patients with localised SS enrolled on the European paediatric Soft tissue sarcoma Study Group (EpSSG) NRSTS2005 and on the Children Oncology Group (COG) ARST0332 trials, treated with surgery alone were eligible for this analysis. Patients must have undergone initial complete resection with histologically free margins, with a grade 2 tumour of any size or a grade 3 tumour ≤5 cm. RESULTS: Sixty patients under 21 years of age were eligible for the analysis; 36 enrolled in the COG (from 2007 to 2012) and 24 in the EpSSG study (from 2005 to 2012). The 3-year event-free survival was 90% (median follow-up 5.2 years, range 1.9-9.1). All eight events were local tumour recurrence, whereas no metastatic recurrences were seen. All patients with recurrence were effectively salvaged, resulting in 100% overall survival. CONCLUSION: This joint prospective analysis showed that patients with adequately resected ≤5 cm SS, regardless of grade, can be safely treated with a surgery-only approach. Avoiding the use of adjuvant chemotherapy and radiotherapy in this low-risk patient population may decrease both short- and long-term morbidity and mortality.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Ferrari A, Chi YY, De Salvo GL, et al. Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group. Eur J Cancer. 2017. PMID: 28391003. doi:10.1016/j.ejca.2017.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。